Clinical

In this white paper we examine the deformulation workflow, demonstrating the value of the technique of Morphologically Directed Raman Spectroscopy (MDRS) within this context. Case studies illustrate the relevance of MDRS data.

Particle agglomeration can compromise the clinical efficacy of pharmaceutical products and must therefore be closely controlled. Automated particle image analysis provides one technology which can aid agglomerate detection. This article provides practical guidance on how imaging can be applied as a routine method to robustly identify and quantify the state of agglomeration of pharmaceutical formulations.

Consider designing the readout first when developing point-of-need assays.

This application note discusses the methodology and results for the rheological characterization of Opthalmic Viscosurgical Devices (OVDs) according to the International Standard ISO15798:2013

The primary value of M4I really lies in the investment in human capital (rather than simply MSI hardware)

Molecular imaging based on mass spectrometry provides a broad scope of analytical, molecular and local information that can be employed for patient phenotyping.

Michael Lämmerhofer opens up about his work on oxidative stress markers and the Chromatographic Society’s Jubilee Award.

At the heart of the drive for increased epidemiological knowledge, faster diagnostics and better-informed treatment decisions are collaborations between medical doctors and analytical specialists.

An ambitious UK sequencing project aims to learn more about patients with cancer and rare diseases

A UK study is set to examine whether new Raman technology can be used to assist surgeons during brain tumor removal.